Pharmacokinetic Analysis of ¹¹¹In-Labeled Liposomal Doxorubicin in Murine Glioblastoma after Blood-Brain Barrier Disruption by Focused Ultrasound

• Feng-Yi Yang ,

  Contributed equally to this work with: Feng-Yi Yang, Hsin-Ell Wang

  * E-mail: fyyang@ym.edu.tw

  Affiliation Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan

  ⨯
• Hsin-Ell Wang ,

  Contributed equally to this work with: Feng-Yi Yang, Hsin-Ell Wang

  Affiliation Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan

  ⨯
• Ren-Shyan Liu,

  Affiliation Department of Nuclear Medicine, National Yang-Ming University Medical School, Taipei Veterans General Hospital, Taipei, Taiwan

  ⨯
• Ming-Che Teng,

  Affiliation Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan

  ⨯
• Jia-Je Li,

  Affiliation Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan

  ⨯
• Maggie Lu,

  Affiliation Drug Delivery Lab, Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, HsinChu, Taiwan

  ⨯
• Ming-Cheng Wei,

  Affiliation Drug Delivery Lab, Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, HsinChu, Taiwan

  ⨯
• Tai-Tong Wong

  Affiliation Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan

  ⨯